SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-20-006480
Filing Date
2020-06-29
Accepted
2020-06-29 09:46:51
Documents
6
Period of Report
2020-06-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K achv-8k_20200629.htm 8-K 42253
2 EX-5.1 achv-ex51_26.htm EX-5 17917
3 EX-10.1 achv-ex101_8.htm EX-10 226947
4 EX-99.1 achv-ex991_6.htm EX-99 12401
5 GRAPHIC g5dxdsqpq30x000001.jpg GRAPHIC 8409
6 GRAPHIC gq440j5zujj5000001.jpg GRAPHIC 18627
  Complete submission text file 0000950123-20-006480.txt   338316
Mailing Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101
Business Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 033-80623 | Film No.: 20996090
SIC: 2835 In Vitro & In Vivo Diagnostic Substances